Cadrenal Therapeutics
BiopharmaPonte Vedra Beach, FL
Total funding$20M#4 of 5 in Biopharma
Founded2022
SectorBiopharma
HQPonte Vedra Beach
About
Cadrenal Therapeutics is a biopharmaceutical company developing a late-stage novel therapy for patients with end-stage renal disease and atrial fibrillation. The company was founded in 2022 and is headquartered in Ponte Vedra Beach, Florida.
Cadrenal Therapeutics is the only Biopharma company we track in Jacksonville — one of 5 across Florida.
Similar companies
View allEnalare TherapeuticsBiopharma | Est. 2019 | SWFL | $76M |
Kincell BioBiopharma | Est. 2023 | GNV | $58M |
ADvantage TherapeuticsBiopharma | Est. 2021 | MIA | $21M |
HalodineBiopharma | Est. 2020 | MIA | $2.3M |
IQ FiberInternet | Est. 2021 | JAX | $150M |
Details
- Region
- Jacksonville / Northeast
- City
- Ponte Vedra Beach
- Founded
- 2022
- Sector
- Biopharma
- Founders
- Matthew Szot
- Website
- cadrenal.com
Jacksonville / Northeast
Jacksonville and the Northeast lean into insurance, logistics around JAXPORT, fintech, and a lower-cost base than the southern metros.
32companies
$542Mraised